CH Arras
Arras, France
NCT Number: NCT05140395
The study confirms the performance equivalence of the in vitro Diagnostic reagent ABTEST card used with the new reformulated WS solution
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Arras, France
The study consists to perform on 100 patients a first pre transfusional control with the reference in vitro reagent ABTEST card (CE Marked reagent) followed by a another pre transfusional control with the in vitro reagent ABTEST card in study (new reformulated WS solution used) .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
66 patients in hematology / oncology departments , including 20 patients with a hemoglobin significantly below the norm (<8g / dl hemoglobin in the blood), and about to receive a transfusion. 20 patients hospitalized in gastroenterology with a transfusion need 4 internal medicine patients with cold agglutinins, in a transfusion context or not.
10 neonatal patients, background transfusion or Guthrie test.
Pre transfusional control with the referent ABTEST card and the in study ABDTEST Card
Time frame: 5 minutes
performance of pre transfusional controls with the referent reagent and the reagent in study
Diagast
Industry
Clinical Perfomance Study of the ABTEST© Card in Vitro Medical Device
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04267029
Acute Lung Injury, Hematologic Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT02200692
Allergy, Hematologic Diseases
Bergen, Norway
View Trial DetailsNCT02841111
Disorder Related to Renal Transplantation, Hematologic Diseases
View Trial DetailsNCT02607150
Hematologic Diseases, Hemic and Lymphatic Diseases
Columbus, Ohio, United States
View Trial Details